DaVita Credit Rating & NNN Cap Rate

DaVita Business Overview & NNN Investment Profile

DaVita Inc. operates as one of the largest dialysis and kidney care providers in the United States, with approximately 2,700 outpatient dialysis centers delivering essential services to patients with end-stage renal disease (ESRD). The company’s primary business model relies on long-term lease agreements for kidney care facilities, making it a critical component of the NNN investment market. DaVita’s revenue of $12.8 billion in FY2024 reflects consistent demand for dialysis services driven by an aging US population.

For investment grade investors seeking exposure to the healthcare sector, DaVita represents an essential service provider with stable long-term lease structures. The company operates under a corporate guarantee on its NNN leases, providing investors with direct recourse to DaVita Inc.’s balance sheet for rent payments and property maintenance obligations. DaVita properties typically range from 6,000 to 8,000 square feet on 0.5 to 1.0 acre lots, with lease terms of 12 years and 2–3% annual escalations, making them attractive for investors seeking stable, predictable cash flows in the healthcare space.

DaVita Credit Rating Analysis

DaVita maintains credit ratings of BB+ from Standard & Poor’s and Ba2 from Moody’s, both with stable outlooks. These ratings place DaVita below the investment grade threshold (which begins at BBB‑/Baa3). The below-investment-grade status reflects several factors, including Medicare reimbursement pressures, regulatory exposure related to dialysis payment reforms, and industry-specific risks inherent to healthcare service providers.

Despite the sub-investment-grade rating, DaVita’s credit profile benefits from the aging US population, which drives consistent demand for dialysis services. The company’s long-term lease structures with 2–3% annual escalations provide inflation protection and predictable cash flows. For NNN investors, understanding the credit nuances is essential. More information on evaluating tenant credit ratings can help investors assess risk-adjusted returns in the healthcare sector.

DaVita NNN Lease Structure

DaVita’s NNN lease agreements typically feature 12-year initial lease terms with corporate guarantees, ensuring investors have direct recourse to DaVita Inc.’s financial strength. Standard lease escalations of 2–3% annually help offset inflation and rising operating costs. Most DaVita facilities include two to three 5-year renewal options, giving tenants and investors flexibility for long-term arrangements.

The typical DaVita facility is a 6,000–8,000 square foot medical office or standalone dialysis center on 0.5–1.0 acre lot. Under NNN structure, DaVita pays all operating expenses, property taxes, insurance, and maintenance costs in addition to base rent. This full-service model ensures investors benefit from stable, net rent without exposure to facility-level operating costs. The specialized use nature of dialysis facilities creates high switching costs and reduced competition, strengthening the long-term lease stability.

DaVita NNN Cap Rate & Pricing Trends

DaVita NNN properties currently trade at cap rates ranging from 5.5% to 6.75%, reflecting the company’s below-investment-grade credit profile and associated risk premium compared to investment-grade healthcare tenants. Pricing for DaVita properties typically ranges from $1.5 million to $3.5 million, depending on location, facility condition, and lease terms. The cap rate spread above investment-grade comparable tenants such as Fresenius Medical Care reflects the credit risk differential in the market.

Market demand for DaVita NNN properties remains steady despite below-investment-grade ratings, as investors recognize the essential nature of dialysis services and the aging population tailwind. Properties with longer remaining lease terms and strong facilities command higher prices and lower cap rates. For guidance on evaluating cap rates and pricing across the NNN spectrum, see the investment grade guide for comprehensive analysis of pricing trends, market factors, and valuation methodologies used by professional NNN investors.

DaVita Real Estate Footprint

With approximately 2,700 US locations, DaVita maintains one of the most geographically diversified real estate footprints in healthcare. The company operates dialysis centers across urban, suburban, and rural markets, reflecting the nationwide prevalence of ESRD and the need for accessible kidney care services. DaVita’s real estate strategy emphasizes high-traffic, accessible locations near hospital systems, physician offices, and patient populations with high ESRD incidence.

Real estate optimization remains an ongoing focus for DaVita, with the company periodically consolidating underperforming locations and opening new facilities in high-growth demographic markets. The diverse footprint reduces geographic concentration risk and provides investors with exposure to varied market conditions and demographics. Real estate quality and location directly impact patient acquisition, operational efficiency, and long-term lease sustainability for NNN investors.

DaVita Growth & Expansion Outlook

DaVita’s growth trajectory is modest, driven primarily by the aging US population and increasing ESRD prevalence. The company projects steady volume growth among aging beneficiaries, with the 65+ population continuing to expand. Expansion efforts focus on opening new centers in high-growth markets and optimizing existing locations rather than aggressive nationwide buildouts.

Key growth drivers include Medicare Advantage plan partnerships, expansion of integrated care models, and value-based care arrangements. However, regulatory headwinds related to dialysis payment reforms and potential Medicare reimbursement changes represent material risks to long-term growth. DaVita’s modest expansion outlook reflects a mature, essential-service market where growth depends more on demographic tailwinds than business innovation.

DaVita NNN Investment: Pros & Cons

Comparable NNN Tenants

Frequently Asked Questions About DaVita NNN Investments